Biodefense Market Report (2021-2031) | The Insight Partners
2021 年生物防御市场规模为 123.7 亿美元,预计到 2031 年将达到 216.2 亿美元。预计 2023-2031 年市场复合年增长率为 6.1%。大数据和人工智能技术为对不同生物威胁的风险和可能性进行技术评估提供了巨大的可能性,并为绘制疾病爆发图提供了无与伦比的机会。因此,预测分析可以帮助重塑生物防御行业,成为生物防御市场的关键趋势。
生物防御市场分析
由于基因工程和生物技术领域的最新科学进步,致命的自然病毒现在可以轻易地被改造,从而造成更大的危害。人们越来越认识到生物袭击和疫情可能造成的灾难性影响,这增加了对生物防御解决方案的需求。世界各国政府都在对生物防御能力进行大量投资,这支持了市场的扩张。技术发展和对研发的日益重视也导致了复杂和创新的生物防御解决方案的推出。生物防御解决方案的发展受到合成生物学、基因组学和数据分析等技术创新的推动,这些技术创新提高了识别、表征和减轻生物威胁的能力。此外,政府、国防和商业组织之间的伙伴关系支持了全面生物防御战略的发展,并促进了市场扩张。
生物防御市场概况
生物防御是指旨在恢复受到或可能受到生物威胁或传染病影响的国家的生物安全的一系列活动和技术。它有助于应对与流行病、生物恐怖主义和其他生物紧急情况有关的潜在风险。美国联邦政府协调计划并制定预算,以防止、应对和采取行动应对生物灾难。美国生物防御计划,也称为国家生物防御战略,需要各级政府与私人机构和其他利益相关者共同努力开展生物防御活动。此外,国家传染病合作中心是加拿大的一个组织,旨在通过网络研讨会、播客、在线资源和出版物向政策制定者、公共卫生从业者、卫生检查员和其他人提供有关新发传染病的最新信息。因此,政府为加强生物防御系统而采取的努力和举措可能会在预测期内支持市场增长。
定制研究以满足您的需求
我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。
生物防御市场:
Biodefense Market: Strategic Insights
Biodefense Market
-
CAGR (2023 - 2031)
6.10%
-
Market Size 2021
US$ 12.37 billion
-
Market Size 2031
US$ 21.62 billion
Key Players
- Bavarian Nordic
- Alnylam Pharmaceuticals Inc
- SIGA Technologies
- Emergent BioSolutions Inc
- Cleveland Bio Labs
- Dynavax Technologies
- Elusys Therapeutics Inc
- Soligenix
- Altimmune
- Pluristem
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
产品(炭疽、天花、肉毒杆菌、辐射、核、其他)
地理
Biodefense Market: Strategic Insights
-
CAGR (2023 - 2031)6.10% -
Market Size 2021
US$ 12.37 billion -
Market Size 2031
US$ 21.62 billion
Key Players
- Bavarian Nordic
- Alnylam Pharmaceuticals Inc
- SIGA Technologies
- Emergent BioSolutions Inc
- Cleveland Bio Labs
- Dynavax Technologies
- Elusys Therapeutics Inc
- Soligenix
- Altimmune
- Pluristem
Regional Overview
- 北美(美国、加拿大、墨西哥)
- 欧洲(英国、德国、法国、俄罗斯、意大利、欧洲其他地区)
- 亚太地区(中国、印度、日本、澳大利亚、亚太地区其他地区)
- 南美洲和中美洲(巴西、阿根廷、南美洲和中美洲其他地区)
- 中东和非洲(南非、沙特阿拉伯、阿联酋、中东和非洲其他地区)
Market Segmentation
复合年增长率(2023 - 2031)6.10%- 2021 年市场规模
123.7 亿美元 - 2031年市场规模
216.2亿美元
市场动态
- 政府出台优惠措施
- 生物武器和核武器威胁日益严重
- 预测分析重塑生物防御市场
- 发展中和欠发达经济体政府研发投入低
关键人物;主力;重要一员
- 巴伐利亚北欧
- Alnylam 制药公司
- 西加科技
- 新兴生物解决方案公司
- 克利夫兰生物实验室
- Dynavax 技术
- Elusys Therapeutics 公司
- 索利吉尼克斯
- 免疫
- 复组织
区域概况
- 北美
- 欧洲
- 亚太
- 南美洲和中美洲
- 中东和非洲
市场细分
- 炭疽病
- 天花
- 肉毒杆菌中毒
- 辐射
- 核
- 其他的
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
生物防御市场驱动因素和机遇
政府出台优惠举措推动市场增长
发达国家的政府采取各种行动并采取预防措施来抵御生物恐怖主义袭击。政府不断维持疫苗和生物威胁检测工具的供应以保护公众。这归因于联邦资金的增加、技术突破和公众意识的提高。主要参与者的存在也对市场有利。2018 年,美国政府发布了《国家生物防御战略和实施计划》、《国家安全战略》、《国家防御战略》、《国家反恐战略》和《国家反大规模杀伤性武器战略》,所有这些都包括生物安全和生物防御。
此外,在印度等新兴市场,国防研究与发展组织等多家机构正在开发防御措施以对抗生物攻击。军队正在做出巨大努力来为生物攻击做好准备。在过去二十年中,各国越来越重视传播生物恐怖主义意识,并提出了各种提案和会议来对抗此类威胁,这是推动生物防御需求的主要原因之一。全球各国政府的举措为参与生物防御领域的公司打开了一扇机会之窗,从而推动了市场增长。
加强技术采用以促进市场增长
越来越多的技术被采用,例如法医部门用于病原体检测的基因芯片、数据库管理系统、生物防御相关药物开发中的先进检测硬件以及纳米技术,这些技术正被成功地用于加强生物防御技术。这些技术中的大多数都被单独或联合用于设计和开发各种生物防御工具。目前对生物防御最重要的技术与基因工程密切相关,基因工程是一种基于人工操纵和转移遗传物质的技术。同时,基因疗法可以有效地用于治疗各种疾病。许多人预测未来的生物武器可能是设计生物武器,这种技术可以在寻找目前未知的许多疾病的治疗方法方面发挥非常重要的作用。分子生物学和基因工程的最新进展导致了新的疫苗开发战略,并可能在未来为生物防御市场创造巨大的增长机会。
生物防御市场报告细分分析
有助于得出生物防御市场分析的关键部分是产品。
生物防御市场份额(按地区)分析
生物防御市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美和中美。
北美一直主导着生物防御市场。对人类、动物和环境的生物威胁是美国及其国家面临的最严重问题之一。随着生物威胁不断增加,美国专注于加强其能力,并将应对生物威胁和生物恐怖主义的准备视为国家安全的关键方面之一。对国家安全的高度重视、完善的医疗保健系统和强大的研发能力有利于该地区市场的增长。由于政府采取了强有力的积极主动行动、与行业参与者建立了合作伙伴关系以及对生物恐怖主义威胁的高度准备,该地区在生物防御技术方面投入了大量资金,包括治疗、疫苗和检测系统。
BARDA、NIAID、CDC、ASPR 和 FDA 等组织实施的生物防御战略正在促进该地区的发展。美国军方和民间机构对生物防御的大量资助也是该地区收入份额最高的关键因素之一。
预计亚太地区未来几年将以最高的复合年增长率增长。由于研发投资不断扩大,生物防御的重要性以及导致紧急情况的危险生物材料威胁日益增加,正在支持该地区的市场增长。该地区对传染病的高度易感性和庞大的人口也增加了对生物防御产品和技术的需求,再加上先进的医疗保健基础设施。
生物防御市场报告范围
报告属性 | 细节 |
---|---|
2021 年市场规模 | 123.7亿美元 |
2031 年市场规模 | 216.2亿美元 |
全球复合年增长率(2023 - 2031) | 6.10% |
历史数据 | 2021-2022 |
预测期 | 2024 - 2031 |
涵盖的领域 | 按产品
|
覆盖地区和国家 | 北美
|
市场领导者和主要公司简介 |
|
- 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。
生物防御市场新闻和最新发展
生物防御市场通过收集一手和二手研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是生物防御市场和战略发展情况的列表:
- 2022 年 2 月,Appili Therapeutics Inc. 宣布通过国防威胁降低局联合科学技术办公室从美国国防部获得超过 1000 万美元的资助,以推进该公司的生物防御候选疫苗ATI-1701,这是一种潜在的首创疫苗候选药物,可预防土拉弗朗西斯菌感染。这笔资金预计将提升该公司在生物防御市场的存在感并促进增长。(来源:Appili Therapeutics,新闻稿,2022 年)
- 2022 年 9 月,Emergent BioSolutions Inc. 与 Chimerix, Inc. 达成最终协议,收购 Chimerix 对 TEMBEXA (brincidofovir) 的全球独家权利,TEMBEXA 是美国食品药品管理局 (FDA) 批准的首个用于治疗所有年龄组天花的口服抗病毒药物。(来源:Emergent BioSolutions Inc.,新闻稿,2022 年)
- 2023年7月,Emergent BioSolutions Inc. 的 CYFENDUS(吸附佐剂炭疽疫苗,以前称为 AV7909)已获得美国 FDA 批准,用于 18 至 65 岁人群在疑似或确诊接触炭疽杆菌后,与推荐的抗菌药物联合使用,进行暴露后预防。(来源:Emergent BioSolutions Inc.,新闻稿,2023 年)
生物防御市场报告范围和交付成果
“生物防御市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:
- 范围内涵盖的所有主要细分市场的全球、区域和国家层面的市场规模和预测
- 市场动态,如驱动因素、限制因素和关键机遇
- 未来主要趋势
- 详细的 PEST/波特五力分析和 SWOT 分析
- 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
- 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
- 详细的公司简介
Biodefense Market Report Scope
Report Attribute | Details |
---|---|
Market size in | US$ 12.37 billion |
Market Size by | US$ 21.62 billion |
Global CAGR | 6.10% |
Historical Data | 2021-2022 |
Forecast period | 2024 - 2031 |
Segments Covered |
By 产品(炭疽、天花、肉毒杆菌、辐射、核、其他) |
Regions and Countries Covered |
北美(美国、加拿大、墨西哥)
|
Market leaders and key company profiles |
|
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
- Bavarian Nordic
- Alnylam Pharmaceuticals, Inc.
- SIGA Technologies
- Emergent BioSolutions Inc.
- Cleveland Bio Labs
- Dynavax Technologies
- Elusys Therapeutics, Inc.
- Soligenix
- Altimmune
- Pluristem
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.